Literature DB >> 20460119

Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.

Ishmael Kasvosve1, Zufan Debebe, Sergei Nekhai, Victor R Gordeuk.   

Abstract

BACKGROUND: Iron deficiency and the Q248H mutation in the gene, SLC40A1, that encodes for the cellular iron exporter, ferroportin, are both common in African children. The iron status of macrophages influences the pro-inflammatory response of these cells. We hypothesized that Q248H mutation may modify the inflammatory response by influencing iron levels within macrophages.
METHODS: The Q248H mutation and circulating concentrations of ferritin, C-reactive protein and selected pro-inflammatory cytokines (interleukin-12, interferon-gamma, TNF-alpha, and macrophage migration inhibitory factor) and anti-inflammatory cytokines (interleukin-4 and interleukin-10) were measured in 69 pre-school children recruited from well-child clinics in Harare, Zimbabwe.
RESULTS: In multivariate analysis, both ferroportin Q248H and ferritin <10ug/L were associated with significantly lower circulating concentrations of tumor necrosis factor-alpha. Ferroportin Q248H but not low iron stores was associated with lower circulating macrophage migration inhibitory factor as well. Anti-inflammatory cytokine levels were not significantly associated with either ferroportin Q248H or iron status.
CONCLUSIONS: Ferroportin Q248H and low iron stores are both associated with lower circulating tumor necrosis factor-alpha, while only ferroportin Q248H is associated with lower circulating macrophage migration inhibitory factor. Whether the reduced production of tumor necrosis factor-alpha observed in ferroportin Q248H heterozygotes may be of significance in anemia of chronic disease is yet to be determined. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460119      PMCID: PMC2921676          DOI: 10.1016/j.cca.2010.04.031

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  49 in total

1.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

2.  In vitro cytokine production in patients with iron deficiency anemia.

Authors:  Michael Bergman; Hanna Bessler; Hertzel Salman; Dimitri Siomin; Rachel Straussberg; Meir Djaldetti
Journal:  Clin Immunol       Date:  2004-12       Impact factor: 3.969

3.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.

Authors:  A T McKie; P Marciani; A Rolfs; K Brennan; K Wehr; D Barrow; S Miret; A Bomford; T J Peters; F Farzaneh; M A Hediger; M W Hentze; R J Simpson
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

4.  Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury.

Authors:  H Tsukamoto; M Lin; M Ohata; C Giulivi; S W French; G Brittenham
Journal:  Am J Physiol       Date:  1999-12

5.  Differential effects of iron deficiency and underfeeding on serum levels of interleukin-10, interleukin-12p40, and interferon-gamma in mice.

Authors:  Solo Kuvibidila; Raj P Warrier
Journal:  Cytokine       Date:  2004-04-21       Impact factor: 3.861

6.  Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene.

Authors:  Victor R Gordeuk; Angela Caleffi; Elena Corradini; Francesca Ferrara; Russell A Jones; Oswaldo Castro; Onyinye Onyekwere; Rick Kittles; Elisa Pignatti; Giuliana Montosi; Cinzia Garuti; Innocent T Gangaidzo; Z A R Gomo; Victor M Moyo; Tracey A Rouault; Patrick MacPhail; Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2003 Nov-Dec       Impact factor: 3.039

7.  Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.

Authors:  Ernest Beutler; James C Barton; Vincent J Felitti; Terri Gelbart; Carol West; Pauline L Lee; Jill Waalen; Chris Vulpe
Journal:  Blood Cells Mol Dis       Date:  2003 Nov-Dec       Impact factor: 3.039

Review 8.  The ferroportin disease.

Authors:  Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

9.  Signaling role of intracellular iron in NF-kappaB activation.

Authors:  Shigang Xiong; Hongyun She; Heigo Takeuchi; Bora Han; John F Engelhardt; C H Barton; Ebrahim Zandi; Cecilia Giulivi; Hidekazu Tsukamoto
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

Review 10.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  4 in total

1.  Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Authors:  Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 2.  Impact of Childhood Malnutrition on Host Defense and Infection.

Authors:  Marwa K Ibrahim; Mara Zambruni; Christopher L Melby; Peter C Melby
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

3.  The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Authors:  John Muthii Muriuki; Alexander J Mentzer; Gavin Band; James J Gilchrist; Tommy Carstensen; Swaib A Lule; Morgan M Goheen; Fatou Joof; Wandia Kimita; Reagan Mogire; Clare L Cutland; Amidou Diarra; Anna Rautanen; Cristina Pomilla; Deepti Gurdasani; Kirk Rockett; Neema Mturi; Francis M Ndungu; J Anthony G Scott; Sodiomon B Sirima; Alireza Morovat; Andrew M Prentice; Shabir A Madhi; Emily L Webb; Alison M Elliott; Philip Bejon; Manjinder S Sandhu; Adrian V S Hill; Dominic P Kwiatkowski; Thomas N Williams; Carla Cerami; Sarah H Atkinson
Journal:  Sci Adv       Date:  2019-09-04       Impact factor: 14.136

4.  Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of P lasmodium infection.

Authors:  Yvette Lufungulo Bahati; Joris Delanghe; Ghislain Bisimwa Balaluka; Karl Vandepoele; Justin Cikomola Cirhuza; Antoine Sadiki Kishabongo; Jan Philippé
Journal:  Heliyon       Date:  2022-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.